Sykehuset Telemark HF

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• ALS (motor neurone disease)1 trial
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Hearing loss1 trial
• Migraine1 trial
• Multiple sclerosis1 trial
• Myelodysplastic syndromes1 trial
• Osteoarthritis1 trial
• Prostate cancer1 trial
• Stroke1 trial

Phase

• Phase 36 trials
• Phase 22 trials
• Phase 2/31 trial

Status

• Recruiting8 trials
• Not yet recruiting2 trials
• Completed1 trial

Lead sponsor

• Oslo University Hospital HF2 trials
• Ascentage Pharma Group Inc.1 trial
• AstraZeneca1 trial
• Guri Hagberg1 trial
• Haukeland University Hospital1 trial
• and 5 more

Running trials

• Recruiting

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· Phase 3· AstraZeneca· Source

• Not yet recruiting

  Vi-Siblin for LARS: A randomized, controlled trial.

  2024-514541-11-00· Phase 2· Sykehuset Telemark HF· Source

• Recruiting

  A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in participants with Amyotrophic Lateral Sclerosis

  2024-513927-18-00· Phase 2· Oslo University Hospital HF· Source

• Recruiting

  The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig)

  2024-517981-40-00· Phase 3· Oslo University Hospital HF· Source

• Recruiting

  Thrombolysis in Factor Xa-inhibitors Trial

  NCT06878066· Phase 3· Guri Hagberg· Source

• Recruiting

  Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

  NCT06641414· Phase 3· Ascentage Pharma Group Inc.· Source

• Recruiting

  Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?

  NCT06025331· Lovisenberg Diakonale Hospital· Source

  Contact: Birthe Marie Roang-Winjum, MD

• Recruiting

  Efficacy of Hyperbaric oxygen in addition to standard treatment for acute sudden deafness

  2024-510798-84-00· Phase 2/3· Helse Bergen HF· Source

• Active, not recruiting

  Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

  NCT04578639· Phase 3· Haukeland University Hospital· Source

• Recruiting

  Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy

  2024-517854-91-00· Phase 3· Pirkanmaan hyvinvointialue· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)1 recruiting
• Atrial fibrillation1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Hearing loss1 recruiting
• Migraine1 recruiting
• Multiple sclerosis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Osteoarthritis1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients.

  NCT06724198· Sykehuset Telemark· Source